Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Display Documents


Institute:
Collection:
Print in Citation style Print version     Display:
Sort by: Display records with Fulltext only
Entries: 1-10  
 Basket 
Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction
Authors: Novoyatleva, T.; Schymura, Y.; Janssen, W.; Strobl, F.; Swiercz, J. M.; Patra, C.; Posern, G.; Wietelmann, A.; Zheng, T. S.; Schermuly, R. T.; Engel, F. B.
Date of Publication (YYYY-MM-DD): 2013
Volume: 108
Issue / Number: 2
Start Page: 325
Document Type: Article
ID: 682172.0
Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction
Authors: Novoyatleva, T.; Schymura, Y.; Janssen, W.; Strobl, F.; Swiercz, J. M.; Patra, C.; Posern, G.; Wietelmann, A.; Zheng, T. S.; Schermuly, R. T.; Engel, F. B.
Date of Publication (YYYY-MM-DD): 2012-09
Title of Journal: FEBS Journal
Volume: 279
Issue / Number: Suppl. 1 Sp. Iss.
Start Page: 302
End Page: 302
Document Type: Article
ID: 625717.0
E2F4 is required for cardiomyocyte proliferation
Authors: van Amerongen, M. J.; Diehl, F.; Novoyatleva, T.; Patra, C.; Engel, F. B.
Date of Publication (YYYY-MM-DD): 2010
Title of Journal: Cardiovasc Res
Volume: 86
Issue / Number: 1
Start Page: 92
End Page: 102
Document Type: Article
ID: 474450.0
TWEAK is a positive regulator of cardiomyocyte proliferation
Authors: Novoyatleva, T.; Diehl, F.; van Amerongen, M. J.; Patra, C.; Ferrazzi, F.; Bellazzi, R.; Engel, F. B.
Date of Publication (YYYY-MM-DD): 2010
Title of Journal: Cardiovasc Res
Volume: 85
Issue / Number: 4
Start Page: 681
End Page: 90
Document Type: Article
ID: 474483.0
E2F4 is required for cardiomyocyte proliferation
Authors: van Amerongen, M. J.; Diehl, F.; Novoyatleva, T.; Patra, C.; Engel, F. B.
Title of Journal: Cardiovasc Res
Volume: 86
Issue / Number: 1
Start Page: 92
End Page: 102
Document Type: Article
ID: 559578.0
TWEAK is a positive regulator of cardiomyocyte proliferation
Authors: Novoyatleva, T.; Diehl, F.; van Amerongen, M. J.; Patra, C.; Ferrazzi, F.; Bellazzi, R.; Engel, F. B.
Title of Journal: Cardiovasc Res
Volume: 85
Issue / Number: 4
Start Page: 681
End Page: 90
Document Type: Article
ID: 559602.0
E2F4 is required for cardiomyocyte proliferation
Authors: van Amerongen, M. J.; Diehl, F.; Novoyatleva, T.; Patra, C.; Engel, F. B.
Title of Journal: Cardiovasc Res
Volume: 86
Issue / Number: 1
Start Page: 92
End Page: 102
Document Type: Article
ID: 559672.0
TWEAK is a positive regulator of cardiomyocyte proliferation
Authors: Novoyatleva, T.; Diehl, F.; van Amerongen, M. J.; Patra, C.; Ferrazzi, F.; Bellazzi, R.; Engel, F. B.
Title of Journal: Cardiovasc Res
Volume: 85
Issue / Number: 4
Start Page: 681
End Page: 90
Document Type: Article
ID: 559694.0
E2F4 is required for cardiomyocyte proliferation
Authors: van Amerongen, M. J.; Diehl, F.; Novoyatleva, T.; Patra, C.; Engel, F. B.
Title of Journal: Cardiovasc Res
Volume: 86
Issue / Number: 1
Start Page: 92
End Page: 102
Document Type: Article
ID: 559770.0
TWEAK is a positive regulator of cardiomyocyte proliferation
Authors: Novoyatleva, T.; Diehl, F.; van Amerongen, M. J.; Patra, C.; Ferrazzi, F.; Bellazzi, R.; Engel, F. B.
Title of Journal: Cardiovasc Res
Volume: 85
Issue / Number: 4
Start Page: 681
End Page: 90
Document Type: Article
ID: 559790.0
Entries: 1-10  
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.